Despite the lack of data on malignant tumors a study on HEK-293T cells suggests that NRF2 might control the expression of CPT1 and CPT2, two isoforms of the enzyme carnitine palmitoyltransferase (CPT) that catalyzes the rate-limiting step of FAO [260]. This evidence concerns the gene CPT2 and cancer.